Robert Flavell, Md, Phd
Clinical trials sponsored by Robert Flavell, Md, Phd, explained in plain language.
-
New PET scan could reveal hidden prostate cancer
Diagnosis OngoingThis early-phase study tests a new PET imaging agent (89Zr-DFO-YS5) that targets a protein called CD46, found on many aggressive prostate cancer cells. About 30 men with advanced, treatment-resistant prostate cancer will receive the agent and then have PET scans to see if it can …
Phase: PHASE1 • Sponsor: Robert Flavell, MD, PhD • Aim: Diagnosis
Last updated May 26, 2026 09:49 UTC
-
New MRI technique aims to see prostate Cancer's acidic secrets
Knowledge-focused OngoingThis early-stage study tests whether a special MRI scan using a safe, injected substance (hyperpolarized bicarbonate) can measure acidity levels in prostate tumors. The goal is to see if this imaging method is feasible and safe in a small group of men scheduled for prostate remov…
Phase: EARLY_PHASE1 • Sponsor: Robert Flavell, MD, PhD • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC
-
New imaging technique could reveal hidden joint inflammation
Knowledge-focused TerminatedThis study tests a new PET imaging method to see where rheumatoid arthritis (RA) is active in the body. About 10 adults with RA will receive a special tracer that highlights inflamed joints. The goal is to improve how doctors detect and monitor RA, not to treat it.
Phase: PHASE1 • Sponsor: Robert Flavell, MD, PhD • Aim: Knowledge-focused
Last updated May 18, 2026 12:09 UTC